Skip to main content
Tianjin Ringpu Bio-Technology Co.,Ltd. logo

Tianjin Ringpu Bio-Technology Co.,Ltd. — Investor Relations & Filings

Ticker · 300119 ISIN · CNE100000TV1 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,285 across all filing types
Latest filing 2022-08-25 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300119

About Tianjin Ringpu Bio-Technology Co.,Ltd.

https://www.ringpu.com

Tianjin Ringpu Bio-Technology Co.,Ltd. is a high-tech enterprise specializing in the research, development, production, and sale of animal health products. The company offers a comprehensive portfolio that includes veterinary biological products, chemical drugs, feed additives, and pet health solutions. Its product range covers vaccines for poultry and livestock, as well as various pharmaceutical formulations such as injections, powders, and oral solutions. Ringpu Bio-Technology emphasizes innovation through its dedicated R&D centers, focusing on disease prevention and treatment to support the global animal husbandry industry. The company provides integrated health management services and high-quality veterinary medicines to ensure food safety and animal welfare.

Recent filings

Filing Released Lang Actions
监事会决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 36th meeting of the 4th Supervisory Board of Tianjin Ruipu Biotechnology Co., Ltd. It includes details about the meeting attendance, voting results, and approvals of various reports and proposals, such as the 2022 semi-annual report and the special report on the use of raised funds. The document also mentions the nomination for the new Supervisory Board members. The text is an official announcement of meeting decisions and related governance matters, not the full reports themselves. It is not a full financial report, earnings release, or management discussion, but rather a governance-related announcement about board resolutions and nominations. Therefore, the best fitting category is Board/Management Information (MANG). The document length is short (1410 characters), and it is clearly an announcement of board meeting resolutions and management changes, not the reports themselves.
2022-08-25 Chinese
关于取得兽药产品批准文号的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the acquisition of an official approval number for a veterinary drug product from the Ministry of Agriculture and Rural Affairs. It details the product, its benefits, and regulatory approval, but does not contain financial data, management changes, or meeting materials. The document is short (1076 characters) and serves as a formal announcement of a regulatory approval rather than a financial report or other filing type. It does not fit into categories like Annual Report, Earnings Release, or Management Reports. It is best classified as a Regulatory Filing (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2022-08-19 Chinese
关于聘任董事会秘书的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the appointment of a new board secretary (董事会秘书) for Tianjin Ringpu Bio-technology Co., Ltd. It details the approval process, qualifications, and background of the appointed individual. There is no financial data, no mention of financial results, no regulatory filings or certifications, and no reference to shareholder votes or meetings. The content clearly relates to a change in senior management or board-related personnel. Therefore, the document fits the category of Board/Management Information (MANG). The document length is short and focused solely on this appointment, confirming it is not a full report or announcement of a report publication.
2022-08-11 Chinese
第四届董事会第四十一次（临时）会议决议公告
Board/Management Information Classification · 100% confidence The document is a formal announcement from Tianjin Ruipu Biotechnology Co., Ltd. regarding the resolution of the 41st (extraordinary) meeting of the 4th Board of Directors. It details the appointment of a new board secretary, including the voting results and biographical information of the appointee. The document references compliance with company law and securities regulations and includes signatures and attachments related to the board meeting. There are no financial statements, earnings data, or detailed financial analysis present. The content focuses on board/management changes, specifically the appointment of a board secretary, which fits the category of Board/Management Information (MANG). The document length is short (1444 characters), and it is not merely an announcement of a report but a substantive announcement of a management change.
2022-08-11 Chinese
独立董事对第四届董事会第四十一次（临时）会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is a formal opinion from independent directors regarding the appointment of a board secretary, referencing compliance with company law and stock exchange regulations. It is not a financial report, earnings release, or any form of shareholder meeting materials. It relates to board/management changes, specifically the appointment of a board secretary. The document length is short and focused on management appointment, fitting the Board/Management Information (MANG) category.
2022-08-11 Chinese
公司章程（2022年7月）
Governance Information Classification · 95% confidence The document is a detailed company charter or articles of association for Tianjin Ringpu Bio-Technology Co., Ltd. It includes comprehensive provisions on company organization, shareholder rights, board structure, share issuance, share transfer, shareholder meetings, and other governance matters. It references Chinese company law and securities law, and covers internal rules and procedures for the company and its shareholders. There is no indication that this is an annual report, financial report, earnings release, or any other type of financial filing. Instead, it is a governance document outlining the company's internal rules and governance practices. Therefore, the appropriate classification is Governance Information (CGR). The document length and detail support this classification with high confidence.
2022-07-04 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.